107 related articles for article (PubMed ID: 3394526)
1. Elevation of the renal enzyme N-acetyl-beta-glucosaminidase in affectively disordered patients.
Garvey MJ; Furlong C; Schaffer CB; Adelman R
Acta Psychiatr Scand; 1988 Mar; 77(3):247-52. PubMed ID: 3394526
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of N-acetyl-beta-glucosaminidase in affective disorders and chemical dependence.
Garvey M; Noyes R; Cook B; Barrickman L; Noel M; Ghosheh R
J Affect Disord; 1990 Aug; 19(4):279-85. PubMed ID: 2146305
[TBL] [Abstract][Full Text] [Related]
3. The effects of age and urine concentration on lysozyme and N-acetyl-beta-D-glucosaminidase (NAG) content in urine.
Houser MT
Ann Clin Biochem; 1986 May; 23 ( Pt 3)():297-302. PubMed ID: 3789636
[TBL] [Abstract][Full Text] [Related]
4. Urinary N-acetyl-beta-glucosaminidase and the selection of children for radiologic evaluation after urinary tract infection.
Johnson CE; Vacca CV; Fattlar D; Fulton DJ; Hall PW
Pediatrics; 1990 Aug; 86(2):211-6. PubMed ID: 2371096
[TBL] [Abstract][Full Text] [Related]
5. [Early diagnosis of renal ischemia in arterial hypertension by means of urine N-acetyl-beta-D-glucosaminidase (author's transl)].
García M; Méndez X; Botey A; Pons JM; Revert L
Med Clin (Barc); 1981 Sep; 77(5):200-4. PubMed ID: 7329141
[TBL] [Abstract][Full Text] [Related]
6. [Study on N-acetyl-beta-glucosaminidase (NAG) activities in the urine. II. The relation between NAG activities and various renal function tests in renal diseases].
Uno E; Sano K
Rinsho Byori; 1984 Apr; 32(4):419-24. PubMed ID: 6471495
[No Abstract] [Full Text] [Related]
7. Urinary N-acetyl- beta-D-glucosaminidase activities in patients with renal disease.
Wellwood JM; Ellis BG; Price RG; Hammond K; Thompson AE; Jones NF
Br Med J; 1975 Aug; 3(5980):408-11. PubMed ID: 1156788
[TBL] [Abstract][Full Text] [Related]
8. Automated assay of N-acetyl-beta-glucosaminidase in normal and pathological human urine.
Tucker SM; Boyd PJ; Thompson AE; Price RG
Clin Chim Acta; 1975 Jul; 62(2):333-9. PubMed ID: 1097134
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of urinary N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase.
Hsu WS; Kao JT; Chen JS
Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):407-9. PubMed ID: 2571671
[TBL] [Abstract][Full Text] [Related]
10. Renal disease in rheumatoid arthritis.
Dieppe PA; Doyle DV; Burry HC; Tucker SM
Br Med J; 1976 Mar; 1(6010):611-2. PubMed ID: 1252848
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of increased urinary N-acetyl-beta-D-glucosaminidase activity in human hypertension: effect of cilazapril therapy.
Simon G; Peterson S
Clin Exp Hypertens A; 1988; 10(5):767-77. PubMed ID: 2972422
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of urinary N-acetyl-beta-D-glucosaminidase activities in surgery].
Kamioka T
Nihon Geka Gakkai Zasshi; 1985 Jun; 86(6):657-68. PubMed ID: 4033621
[TBL] [Abstract][Full Text] [Related]
13. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 6. Preclinical evaluation of the urinary NAG activity and its relation to kidney function tests].
Sano K; Uno E
Rinsho Byori; 1983 Sep; Spec No 56():111-21. PubMed ID: 6663752
[No Abstract] [Full Text] [Related]
14. Urinary excretion of N-acetyl-beta-D-glucosaminidase in children with type I diabetes mellitus.
Ellis EN; Brouhard BH; Lagrone L; Travis LB
Diabetes Care; 1983; 6(3):251-5. PubMed ID: 6347577
[TBL] [Abstract][Full Text] [Related]
15. Chronic renal tubular effects in relation to urine cadmium levels.
Mueller PW; Smith SJ; Steinberg KK; Thun MJ
Nephron; 1989; 52(1):45-54. PubMed ID: 2565539
[TBL] [Abstract][Full Text] [Related]
16. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease.
Kunin CM; Chesney RW; Craig WA; England AC; DeAngelis C
Pediatrics; 1978 Nov; 62(5):751-60. PubMed ID: 364392
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
[TBL] [Abstract][Full Text] [Related]
18. Urinary N-acetyl-beta-D-glucosaminidase (NAG) as an indicator of renal disease.
Price RG
Curr Probl Clin Biochem; 1979; (9):150-63. PubMed ID: 446070
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effect of aminoglycosides on excretion of N-acetyl-beta-glucosaminidase.
Fujita K; Murayama T; Kawamura M; Narita K
Int J Clin Pharmacol Res; 1987; 7(6):477-80. PubMed ID: 3440638
[TBL] [Abstract][Full Text] [Related]
20. Urinary N-acetyl-beta-D-glucosaminidase and serum creatinine concentrations predict impaired excretion of methotrexate.
Goren MP; Wright RK; Horowitz ME; Crom WR; Meyer WH
J Clin Oncol; 1987 May; 5(5):804-10. PubMed ID: 3471866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
